Rituximab Plus Chemotherapy Provides No Clinical Benefit in...

Rituximab Plus Chemotherapy Provides No Clinical Benefit in a Peripheral T-Cell Lymphoma Not Otherwise Specified with Aberrant Expression of CD20 and CD79a: A Case Report and Review of the Literature

Mangogna, Alessandro, Cox, Maria Christina, Ruco, Luigi, Lopez, Gianluca, Belmonte, Beatrice, Di Napoli, Arianna
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Journal:
Diagnostics
DOI:
10.3390/diagnostics10060341
Date:
May, 2020
File:
PDF, 2.00 MB
2020
Conversion to is in progress
Conversion to is failed